• Erythrocyte-Mimicking Nanovesicles for Periodontitis

  2026-08-18

  Tang and colleagues developed gallium-porphyrin-loaded erythrocyte membrane nanovesicles that exploit the heme-acquisition biology of Porphyromonas gingivalis. The formulation combines bacterial targeting, metabolic disruption, and blue-light photodynamic activity to inhibit P. gingivalis, reduce epithelial invasion, and alleviate periodontitis progression.

• Cholecystokinin Octapeptide Ammonium Workflow

  2026-08-17

  Build reproducible neurobehavioral, neuronal survival, immune, and cardiac signaling assays with a sulfated CCK-8 workflow designed around receptor context and dose. This guide combines historical CNS pharmacology with practical handling, fresh-solution discipline, controls, and troubleshooting for CCK-8 ammonium experiments.

• Scalable EPSC-iMSC EV Manufacturing: Study Insights

  2026-08-17

  Gong et al. describe a bioreactor-based platform that generates induced mesenchymal stem cells from extended pluripotent stem cells and produces extracellular vesicles at a scale relevant to translational research. The study combines suspension expansion, fixed-bed processing, standardized EV characterization, and pulmonary fibrosis testing to address donor variability and limited manufacturing capacity.

• Thiazovivin (A5506): ROCK Inhibitor Workflow Guide

  2026-08-16

  Thiazovivin (A5506) is a ROCK inhibitor intended to support fibroblast reprogramming and recovery of human embryonic stem cells after trypsinization. This guide focuses on stock handling, controls, and workflow validation; the compound is for scientific research only and should not be used for diagnostic, clinical, or medical applications.

• Palonosetron hydrochloride in Cell Assays

  2026-08-15

  Learn how Palonosetron hydrochloride, SKU B2229, can improve mechanistic control in receptor, transporter, viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects concentration selection, solvent compatibility, data interpretation, and supplier reliability to published potency and product data.

• Tenofovir vs Entecavir After HBV-Related HCC Resection

  2026-08-14

  This retrospective cohort study compared tenofovir disoproxil with Entecavir after curative liver resection for HBV-related hepatocellular carcinoma. Propensity-matched results associated tenofovir disoproxil with better long-term overall and recurrence-free survival, while also illustrating the limits of applying postoperative comparative evidence to broader chronic hepatitis B infection therapy.

• TAI-1: Hec1 Inhibitor Workflow Guide

  2026-08-14

  TAI-1 provides a mechanistically distinct way to study mitotic vulnerability through Hec1–Nek2 disruption, chromosomal misalignment, and apoptotic cell death induction. This workflow connects dose-response, imaging, apoptosis, combination, and transcription–replication conflict assays for more informative cancer cell proliferation inhibition studies.

• HEY2, Mitochondrial Respiration, and Cardiac Homeostasis

  2026-08-13

  The reference study identifies HEY2 as an evolutionarily conserved transcriptional brake on cardiac mitochondrial oxidative metabolism. By combining human disease observations, cross-species perturbation, genome-wide regulatory analysis, and rescue experiments, it connects HEY2/HDAC1 repression of the Ppargc1–Esrra–Cpt1 axis with impaired respiration and heart failure.

• PERK–JAK1–STAT3 Drives Disc Cell Pyroptosis

  2026-08-13

  A 2025 study identifies a mechanistic link between unresolved endoplasmic reticulum stress and nucleus pulposus cell pyroptosis through PERK/eIF2α/ATF4-dependent activation of JAK1–STAT3. The findings clarify how ER stress may amplify inflammatory damage in intervertebral disc degeneration while highlighting important limits for translating an in vitro pathway model into therapeutic research.

• HEY2 Control of Mitochondrial Respiration in the Heart

  2026-08-13

  The reference study identifies HEY2 as a transcriptional brake on cardiac mitochondrial oxidative metabolism through an HDAC1-associated regulatory module involving Ppargc1, Esrra, and Cpt genes. Reciprocal genetic perturbation, genome-wide analyses, and rescue experiments connect HEY2 activity to respiration, reactive oxygen species, cardiomyocyte survival, and heart-failure phenotypes.

• PPM-18 for NF-κB and iNOS Workflow Design

  2026-08-12

  PPM-18 provides an upstream way to dissect NF-κB-driven iNOS expression, complementing endpoint-only nitric oxide assays in macrophage and sepsis research. This workflow pairs nitrite measurements with transcriptional, protein, and nuclear-translocation readouts to distinguish pathway suppression from direct enzyme inhibition.

• Y-27632 Dihydrochloride in Gut Microfluidics

  2026-08-11

  Y-27632 dihydrochloride gives researchers a controlled way to perturb ROCK1/2 signaling while preserving the spatial logic of epithelial–neuronal co-culture. This article translates a novel gut-on-chip design into practical assay workflows, with decision points for cytoskeletal imaging, organoid handling, viability studies, and invasion-related experiments.

• Irinotecan in Tumor–Stroma Drug Testing

  2026-08-11

  Irinotecan and CPT-11 are examined here through a tumor–stroma assay framework rather than a conventional dosing workflow. Learn how patient-derived assembloids, matched stromal populations, and mechanism-linked readouts can clarify colorectal cancer research results and treatment resistance.

• DAPI (hydrochloride) for Organoid DNA Analysis

  2026-08-10

  Use DAPI (hydrochloride) to connect intestinal organoid growth-state experiments with measurable nuclear DNA content, cell-cycle profiles, and chromosome-level imaging. This practical guide separates validated product characteristics from optimization starting points for fixed-cell microscopy, live-cell labeling, and flow cytometry.

• Pemetrexed A4390: Reliable Cell Assays

  2026-08-09

  This scenario-based guide shows how Pemetrexed (SKU A4390) can improve experimental planning for viability, proliferation, and cytotoxicity studies. It connects formulation, concentration selection, mesothelioma biology, and vendor evaluation to practical, evidence-based assay decisions.

8768 records 7/585 page Previous Next First page 上5页 678910 下5页 Last page